Ceruloplasmin immunoreactivity in neurodegenerative disorders

Free Radical Research

Volumn 35, Issue 2, 2001, Pages 111-118

  Loeffler, D A ^a,b   Sima, A A F ^a   LeWitt, P A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Ceruloplasmin; Huntington's disease; Oxidative stress; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

ACUTE PHASE PROTEIN; ANTIOXIDANT; CERULOPLASMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CAUDATE NUCLEUS; CONTROLLED STUDY; DEGENERATIVE DISEASE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NEUROFIBRILLARY TANGLE; PARIETAL LOBE; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; SENILE PLAQUE; SUBICULUM; SUBSTANTIA NIGRA;

EID: 0034896516     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760100300651     Document Type: Article

References (33)

1. Caeruloplasmin: Physiological and pathological perspectives
2. The inhibition of lipid autoxidation by human serum and its relation to serum proteins and α-tocopherol
3. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum
4. Ceruloplasmin: An acute phase reactant and anti-oxidant
5. Peroxynitrite releases copper from caeruloplasmin: Implications for atherosclerosis
6. Ceruloplasmin enhances DNA damage induced by hydrogen peroxide in vitro
7. Oxidative stress, mitochondrial respiration, and Parkinson's disease
8. Oxidative alterations in Alzheimer's disease
9. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex
10. Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy
11. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration
12. Free radicals in brain metabolism and pathology
13. Increased ceruloplasmin concentrations in Alzheimer's and Parkinson's disease brain regions
14. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
15. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism
16. Increased lipid peroxidation in the brains of aceruloplasminemia patients
17. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease
18. Measurement of acute phase proteins in the rat brain: Contribution of vascular contents
19. Diagnosis of Alzheimer's disease
20. Neuropathological classification of Huntington's disease
21. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II, Standardization of the neuropathologic assessment of Alzheimer's disease
22. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)
23. Neuropathology of Parkinson's disease
24. Visualization of peptide-immunoreactive processes of serotonin-immunoreactive cells using two color immunoperoxidase staining
25. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes
26. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin
27. Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia
28. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
29. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro
30. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
31. Ceruloplasmin gene expression in the murine central nervous system
32. Binding and uptake of copper from ceruloplasmin
33. Plasma ceruloplasmin: Evidence for its presence in and uptake by heart and other organs of the rat